PATENT CLAIM ANALYSIS

Application Number: 15771210
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["435", "007100"]

Abstract:
Disclosed are systems and methods for detecting the sample concentration of cardiac troponin I (cTnI) and the sample concentration of soluble urokinase receptor (suPAR) to determine if a subject has or is at risk for developing cardiovascular disease or a complication of previously diagnosed cardiovascular disease.

Claim (Index 5):
The method of  claim 4 , wherein said CVD therapeutic is selected from the group consisting of: an antibiotic, a probiotic, an alpha-adrenergic blocking drug, an angiotensin-converting enzyme inhibitor, an antiarrhythmic drug, an anticoagulant, an antiplatelet drug, a thrombolytic drug, a beta-adrenergic blocking drug, a calcium channel blocker, a brain acting drug, a cholesterol-lowering drug, a digitalis drug, a diuretic, a nitrate, a peripheral adrenergic antagonist, and a vasodilator.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.34211
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12520718', '15062759', '14312298', '13184115', '13798547']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6645733150841759
- 35 USC 102 Novelty (BERT): 0.512185998077326
- Combined Prediction Score: 0.6493345833834909
- Mean Citation Score: 263.76421
- Max Citation Score: 282.89346
- Similarity Product: 172.46134852056738

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test